Who Is a Good Candidate for Treatment
CNV is most commonly linked to the wet form of age-related macular degeneration, also called neovascular AMD. This is the more advanced and faster-moving type of macular degeneration. Age-related macular degeneration affects more than 11 million people in the United States (BrightFocus Foundation, 2023). Among those with the wet form, CNV is the process that causes the most serious vision loss. If you have been told you have wet AMD, you are a strong candidate for CNV treatment.
People in their fifties and beyond are at the highest risk for developing AMD-related CNV. Other factors that raise your risk include a family history of macular degeneration, smoking, high blood pressure, and having light-colored eyes. If you have dry AMD, your retina specialist will monitor you closely because dry AMD can progress to the wet form at any time.
Pathologic myopia, which is severe nearsightedness, can also lead to CNV. When the eye is much longer than normal, the retinal layers stretch and thin out over time. This stretching can cause breaks in a structure called Bruch's membrane. Bruch's membrane is a thin barrier between the retina and the choroid, which is the layer of blood vessels that nourishes the retina. When this barrier is damaged, abnormal vessels can push through and grow into the retinal space.
Younger adults and middle-aged adults with high myopia should be aware of CNV as a possible complication. If you notice a sudden change in your central vision, such as new blurriness or a dark spot, contact your eye care team right away. Early treatment offers the best chance of preserving your sight.
While AMD and high myopia are the most common causes of CNV, other conditions can also trigger abnormal blood vessel growth. These include ocular histoplasmosis syndrome, which is caused by a fungal infection that leaves scars in the eye. Angioid streaks, which are tiny cracks in Bruch's membrane, can also lead to CNV. Trauma to the eye, certain inflammatory conditions, and some inherited retinal disorders may play a role as well.
If you have been diagnosed with any condition that affects the choroid or Bruch's membrane, your retina specialist may recommend regular monitoring to catch any signs of CNV early. Treatment is available regardless of the underlying cause.
Anyone who notices a sudden shift in their central vision should be evaluated promptly. Symptoms that may point to CNV include blurred or distorted central vision, straight lines that appear wavy or bent, a dark or blank spot in the center of your visual field, and colors that seem faded or washed out. These changes can happen quickly, sometimes over just a few days or weeks.
You do not need a prior diagnosis of AMD or myopia to be a candidate for evaluation. If you are experiencing any of these symptoms, your eye care provider can perform tests to determine whether CNV is present and recommend a treatment plan tailored to your needs.
CNV treatment is not a single event. It requires a commitment to follow-up visits and, in many cases, repeated treatments over months or years. The best outcomes are seen in people who attend their scheduled appointments and communicate openly with their care team about any vision changes. If you are ready to take an active role in protecting your eyesight, you are a good candidate for treatment.
Your retina specialist will work with you to create a monitoring schedule that fits your life. Many patients find that staying on track with their treatment plan becomes a comfortable routine over time.
How Choroidal Neovascularization Works
To understand CNV, it helps to know a little about the structures at the back of your eye. The choroid is a layer of blood vessels that sits just beneath the retina. Its job is to supply oxygen and nutrients to the outer layers of the retina, including the photoreceptor cells that detect light. Between the choroid and the retina lies Bruch's membrane, a thin but important barrier that controls what passes between these two layers.
In a healthy eye, Bruch's membrane keeps the blood vessels of the choroid neatly separated from the retina. When this membrane is weakened or damaged by disease, aging, or other factors, it can develop tiny breaks. These breaks create openings that allow new blood vessels to push through into areas where they do not belong.
When the body senses that retinal tissue is not getting enough oxygen, it sends chemical signals to trigger the growth of new blood vessels. One of the key chemicals involved is called vascular endothelial growth factor, or VEGF. In CNV, VEGF levels become too high, and new blood vessels sprout from the choroid and grow through the breaks in Bruch's membrane into the space beneath or within the retina.
These new vessels are not like the healthy blood vessels in your eye. They are fragile, poorly formed, and prone to leaking. When they leak blood and fluid, the surrounding retinal tissue swells and becomes damaged. This swelling, called macular edema, disrupts the precise arrangement of cells that your eye needs for clear central vision.
The macula is the small, specialized area at the center of the retina. It is responsible for the sharp, detailed vision you use for reading, driving, and recognizing faces. Because the macula is so densely packed with photoreceptor cells, even a small amount of fluid or blood can cause noticeable vision problems.
CNV tends to develop in or near the macula because this area has the highest demand for oxygen and nutrients. When abnormal vessels leak in this region, the damage to your central vision can be significant. Peripheral vision, which is the vision you use to see things off to the side, is usually not affected by CNV.
Without treatment, CNV can progress rapidly. Leaked blood and fluid can accumulate beneath the retina, lifting it away from its normal position. Over time, the abnormal blood vessels may form a scar, called a disciform scar, which replaces the healthy retinal tissue. Once scarring occurs, the vision loss it causes is usually not reversible.
This is why prompt treatment is so important. The goal of therapy is to stop the leaking, reduce swelling, and prevent further damage before scarring has a chance to develop. In many cases, treatment can stabilize vision and, for some patients, even improve it.
Treatment Options for Choroidal Neovascularization
The primary treatment for CNV is anti-VEGF injection therapy. These medications work by blocking the chemical signal, VEGF, that drives the growth of abnormal blood vessels. By reducing VEGF levels in the eye, these injections help shrink existing abnormal vessels, stop new ones from forming, and reduce the leaking of blood and fluid.
Anti-VEGF medications are delivered directly into the eye through a very fine needle. While the idea of an eye injection may sound alarming, the procedure is quick, and numbing drops are used to minimize discomfort. Most patients describe feeling only mild pressure during the injection. Several anti-VEGF medications are available, and your retina specialist will recommend the one best suited to your condition.
- Blocks the growth signal that causes abnormal blood vessels to form
- Reduces fluid leakage and macular swelling
- Can stabilize and, in some cases, improve vision
- Given as a series of injections, with the schedule tailored to your response
Photodynamic therapy, or PDT, is another treatment option for certain types of CNV. During PDT, a light-sensitive medication is injected into a vein in your arm. This medication travels through your bloodstream and collects in the abnormal blood vessels in your eye. Your retina specialist then shines a special low-energy laser into your eye. The laser activates the medication, which creates a reaction that helps close off the leaking vessels.
PDT is sometimes used when anti-VEGF therapy alone is not enough, or for specific types of CNV that respond well to this approach. It may be combined with anti-VEGF injections for a more comprehensive treatment plan. Your care team will explain whether PDT is appropriate for your situation.
Laser photocoagulation uses a focused beam of thermal energy to seal off abnormal blood vessels. This treatment creates small, controlled areas of tissue scarring that stop the vessels from leaking. Laser photocoagulation is most useful when the abnormal vessels are located away from the center of the macula, because the laser itself can cause a small blind spot in the treated area.
This option is less commonly used today than it was in the past, thanks to the effectiveness of anti-VEGF therapy. However, it may still be recommended in certain cases, especially when CNV is located in a position where laser treatment can be applied safely without affecting central vision.
In some cases, your retina specialist may recommend a combination of treatments. For example, anti-VEGF injections may be paired with photodynamic therapy to target the abnormal vessels from two different angles. This approach can be helpful for patients whose CNV does not respond fully to a single type of treatment.
The choice of treatment depends on several factors, including the location and size of the abnormal vessels, the underlying cause of your CNV, how your eye responds to initial treatment, and your overall eye health. Your care team will discuss the options with you and develop a plan that gives you the best chance of preserving your vision.
In rare cases, your retina specialist may recommend close monitoring before starting active treatment. This might apply if the CNV is very small, located far from the center of the macula, or not currently leaking. During this watchful period, you will have frequent eye exams and imaging tests so that any changes can be detected quickly.
If monitoring is recommended, it does not mean your condition is unimportant. It means your specialist believes that the risks of treatment may currently outweigh the benefits and that careful observation is the safest approach for now. Treatment can begin promptly if the condition changes.
What to Expect During and After Treatment
On the day of your injection, you will be welcomed into a clean treatment room. Your care team will review your current symptoms and may perform imaging tests to check the status of the abnormal vessels. Before the injection, numbing drops will be placed in your eye. An antiseptic solution will also be applied to reduce the risk of infection.
The injection itself takes only a few seconds. You may feel a brief sensation of pressure, but most patients report little to no pain. After the injection, your eye may be slightly red or irritated, and you might notice small floating spots in your vision. These effects are normal and usually resolve within a day or two.
After your injection, you can usually return to most of your normal activities the same day. Your care team may ask you to avoid rubbing your eye and to use antibiotic eye drops for a few days to prevent infection. It is normal to experience mild discomfort, a gritty feeling in the eye, or slight blurriness for a short time after the procedure.
Contact your retina specialist right away if you experience any of the following symptoms after treatment.
- Severe eye pain that does not improve
- Significant decrease in vision
- Increasing redness or swelling around the eye
- Flashes of light or a sudden increase in floating spots
- A shadow or curtain effect in your peripheral vision
Anti-VEGF treatment for CNV is not a one-time event. Most patients start with a series of monthly injections, often for three months in a row. After this initial phase, your retina specialist will assess how your eye is responding and adjust your treatment schedule. Some patients transition to a 'treat and extend' approach, where the time between injections is gradually lengthened as long as the condition remains stable.
Follow-up visits typically include a vision check and imaging tests such as optical coherence tomography, or OCT. OCT uses light waves to create detailed cross-section images of your retina, allowing your specialist to see whether fluid or swelling is still present. These visits are essential for tracking your progress and making timely adjustments to your treatment plan.
Your retina specialist uses advanced imaging tools to monitor your CNV closely. OCT is the most frequently used test. It is painless, takes only a few minutes, and provides a detailed view of the layers of your retina. Your specialist will look for signs of fluid, changes in retinal thickness, and any new blood vessel activity.
Fluorescein angiography is another important test. During this procedure, a special dye is injected into a vein in your arm. As the dye travels through the blood vessels in your eye, a camera takes rapid photographs. These images show where blood vessels are leaking and help your specialist plan your treatment. This test is usually done at your initial evaluation and may be repeated periodically.
With consistent treatment, many patients are able to stabilize their vision and prevent further loss. Some patients experience meaningful improvement in their visual sharpness, especially when treatment begins early. It is important to understand that the goal of treatment is to manage the condition and protect your remaining sight. Results vary from person to person depending on the severity of the CNV, how quickly treatment was started, and how well the eye responds to therapy.
Some patients may need ongoing treatment for several years. Others may eventually be able to reduce the frequency of their injections. Your retina specialist will guide you through these decisions and help you understand what to expect at each stage of your care.
Your Journey Through CNV Treatment Step by Step
Your journey begins when you notice a change in your vision. Common early signs of CNV include blurry or distorted central vision, straight lines that appear wavy, a dark or gray area in the center of your sight, and difficulty reading or seeing fine details. These symptoms may develop gradually or appear quite suddenly.
If you experience any of these changes, schedule an appointment with your eye care provider as soon as possible. Early evaluation gives you the best chance of starting treatment before significant damage occurs. Do not wait for symptoms to worsen before seeking help.
At your first visit, your retina specialist will perform a thorough examination of your eyes. This includes checking your visual acuity, which measures how clearly you can see at various distances. You will also have your pupils dilated so that your specialist can examine the retina directly.
Diagnostic imaging plays a central role in confirming a diagnosis of CNV. Your evaluation will likely include the following tests.
- Optical coherence tomography (OCT) to view the layers of your retina in fine detail
- Fluorescein angiography to identify leaking blood vessels
- OCT angiography, a newer imaging technique that maps blood flow without the need for dye injection
- Fundus photography to create a detailed photograph of the back of your eye
Once your diagnosis is confirmed, your retina specialist will discuss your treatment options with you. The plan will be based on the type, size, and location of your CNV, as well as your overall eye health and any other medical conditions you may have. For most patients, anti-VEGF injection therapy is the first line of treatment.
Your specialist will explain the expected treatment schedule, what each visit will involve, and how progress will be measured. This is a good time to ask questions and share any concerns. Understanding your treatment plan helps you feel more confident and prepared as you move forward.
Your first treatment session will typically be scheduled soon after your diagnosis, because early intervention is important. The injection process follows the steps described earlier in this guide. Your care team will make sure you are comfortable and informed throughout the procedure.
After your first injection, you will return for follow-up visits as directed. Most treatment protocols begin with monthly injections during the initial phase. Your specialist will monitor your response closely and adjust the plan as needed. Each visit is an opportunity to check your progress and ensure that your treatment is working effectively.
As your treatment continues, your retina specialist will use imaging tests to track how well the abnormal blood vessels are responding. If the fluid is resolving and your retina is stabilizing, the interval between injections may be gradually extended. If the condition is not responding as expected, your specialist may adjust the medication or recommend adding another treatment approach.
Staying on schedule with your appointments is one of the most important things you can do for your eye health. Consistent follow-up care helps your retina specialist detect any changes early and adjust your treatment plan before problems progress.
Managing CNV is a long-term commitment, and your quality of life matters throughout the process. Many patients find it helpful to use assistive devices such as magnifying glasses, large-print materials, and improved lighting to make daily tasks easier. Your care team can connect you with low vision rehabilitation services if needed.
Lifestyle choices can also support your eye health. Eating a diet rich in leafy green vegetables and fish, maintaining a healthy weight, managing blood pressure, and not smoking all contribute to overall retinal health. While these steps cannot replace medical treatment, they support the health of your eyes and your body as a whole.
Questions and Answers
Choroidal neovascularization is a condition in which abnormal blood vessels grow beneath the retina. These vessels are fragile and can leak blood and fluid, which damages the macula and affects your central vision. Central vision is what you use to see things directly in front of you, such as words on a page or a person's face.
CNV does not typically affect your peripheral vision, so you can still see things off to the side. However, the loss of central vision can make many everyday tasks more difficult. Treatment is focused on stopping the leaking and protecting the vision you have.
Your retina specialist uses several tools to diagnose CNV. A dilated eye exam allows your doctor to look at the retina directly. Optical coherence tomography, or OCT, creates detailed images of the retinal layers and can show areas of swelling or fluid. Fluorescein angiography involves injecting a special dye into your bloodstream and photographing the blood vessels in your eye to find areas of leaking.
These tests are safe, widely used, and provide the detailed information your specialist needs to confirm a diagnosis and plan your treatment. You may have some or all of these tests during your evaluation.
CNV is a chronic condition, meaning it requires ongoing management. Anti-VEGF injections work by blocking the chemical signal that causes abnormal blood vessels to grow and leak. The effect of each injection lasts for a limited time, so repeated treatments are needed to keep the condition under control.
Think of it like managing blood pressure with medication. Just as blood pressure medicine needs to be taken regularly to remain effective, anti-VEGF injections need to be given on a schedule to maintain their benefit. Over time, some patients are able to extend the time between injections as their condition stabilizes.
Delaying treatment or stopping it prematurely can allow the abnormal blood vessels to become active again. When leaking resumes, additional damage can occur to the macula. In some cases, this damage leads to scarring that causes vision loss that is difficult to reverse. The longer CNV goes untreated, the greater the risk of harm to your sight.
If you are having difficulty keeping up with your treatment schedule, talk to your care team. They can help you find solutions and adjust your plan to make it more manageable. Staying engaged with your treatment gives you the best chance of maintaining your vision over the long term.
Between office visits, your retina specialist may ask you to monitor your vision at home using a simple tool called an Amsler grid. This is a small card with a grid pattern and a dot in the center. You look at the dot one eye at a time and note whether the lines appear straight or wavy. Any new waviness, blurriness, or missing areas should be reported to your care team right away.
Home monitoring does not replace professional eye exams, but it helps you stay aware of changes between visits. Catching a change early means treatment adjustments can be made quickly, which supports better outcomes over time.
While lifestyle changes cannot treat CNV on their own, they can support your overall eye health and complement your medical treatment. Smoking is one of the strongest modifiable risk factors for macular degeneration and CNV. If you smoke, quitting is one of the most impactful steps you can take for your eye health.
A balanced diet that includes plenty of leafy greens, colorful fruits and vegetables, and omega-3 fatty acids from fish may help support retinal health. Keeping your blood pressure and cholesterol at healthy levels also benefits the blood vessels throughout your body, including those in your eyes. Your care team can provide personalized guidance on lifestyle strategies that may help you.